Impact of penicillin nonsusceptibility on clinical outcomes of patients with nonmeningeal Streptococcus pneumoniae bacteremia in the era of the 2008 Clinical and Laboratory Standards Institute penicillin breakpoints

Antimicrobial Agents and Chemotherapy

Volumn 56, Issue 9, 2012, Pages 4650-4655

  Choi, Seong Ho ^a   Chung, Jin Won ^a   Sung, Heungsup ^b   Kim, Mi Na ^b   Kim, Sung Han ^b   Lee, Sang Oh ^b   Kim, Yang Soo ^b   Woo, Jun Hee ^b   Choi, Sang Ho ^b  

^a Chung Ang University College of Medicine   (South Korea)

^b University of Ulsan College of Medicine   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

CARBAPENEM; CEFTRIAXONE; CEPHALOSPORIN DERIVATIVE; CLINDAMYCIN; COTRIMOXAZOLE; ERYTHROMYCIN; LEVOFLOXACIN; PENICILLIN G; QUINOLINE DERIVED ANTIINFECTIVE AGENT; TETRACYCLINE; VANCOMYCIN;

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; ANTIBACTERIAL ACTIVITY; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTEREMIA; CHILD; CLINICAL PRACTICE; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE SEVERITY; FATALITY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRESCHOOL CHILD; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RISK FACTOR; SCHOOL CHILD; SEX RATIO; STREPTOCOCCUS PNEUMONIA; STREPTOCOCCUS PNEUMONIAE; TREATMENT OUTCOME;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; CARBAPENEMS; CEFTRIAXONE; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; INFANT; LENGTH OF STAY; MALE; MIDDLE AGED; PENICILLIN RESISTANCE; PENICILLINS; PNEUMOCOCCAL INFECTIONS; RETROSPECTIVE STUDIES; STREPTOCOCCUS PNEUMONIAE; SURVIVAL RATE; TREATMENT OUTCOME; VANCOMYCIN;

EID: 84865440925     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.00239-12     Document Type: Article

References (30)

1. Aspa J, et al. 2004. Drug-resistant pneumococcal pneumonia: clinical relevance and related factors. Clin. Infect. Dis. 38:787-798. (Pubitemid 38387224)
2. Bone RC, et al. 1992. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. ACCP/SCCM Consensus Conference on Sepsis and Organ Failure. Chest 101:1644-1655.
3. Charlson ME, Pompei P, Ales KL, MacKenzie CR. 1987. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J. Chronic Dis. 40:373-383. (Pubitemid 17055592)
4. Choi EH, Lee HJ. 1998. Clinical outcome of invasive infections by penicillin-resistant Streptococcus pneumoniae in Korean children. Clin. Infect. Dis. 26:1346-1354.
5. CLSI. 2008. Performance standards for antimicrobial susceptibility testing. CLSI document M100-S18. Clinical and Laboratory Standards Institute, Wayne, PA.
6. Ewig S, et al. 1999. Pneumonia acquired in the community through drug-resistant Streptococcus pneumoniae. Am. J. Respir. Crit. Care Med. 159:1835-1842. (Pubitemid 29275052)
7. Falcó V, et al. 2004. Influence of penicillin resistance on outcome in adult patients with invasive pneumococcal pneumonia: is penicillin useful against intermediately resistant strains? J. Antimicrob. Chemother. 54:481-488. (Pubitemid 39177474)
8. Feikin DR, et al. 2000. Mortality from invasive pneumococcal pneumonia in the era of antibiotic resistance, 1995-1997. Am. J. Public Health 90:223-229. (Pubitemid 30062674)
9. Figueiredo AM, Connor JD, Severin A, Vaz Pato MV, Tomasz A. 1992. A pneumococcal clinical isolate with high-level resistance to cefotaxime and ceftriaxone. Antimicrob. Agents Chemother. 36:886-889.
10. Goldstein B, Giroir B, Randolph A, International Consensus Conference on Pediatric Sepsis. 2005. International pediatric sepsis consensus conference: definitions for sepsis and organ dysfunction in pediatrics. Pediatr. Crit. Care Med. 6:2-8.
11. Ho PL, et al. 2006. Clinical outcomes of bacteremic pneumococcal infections in an area with high resistance. Eur. J. Clin. Microbiol. Infect. Dis. 25:323-327.
12. Kaplan SL, et al. 2001. Outcome of invasive infections outside the central nervous system caused by Streptococcus pneumoniae isolates nonsusceptible to ceftriaxone in children treated with beta-lactam antibiotics. Pediatr. Infect. Dis. J. 20:392-396. (Pubitemid 32294747)
13. Kim SH, et al. 2012. Changing trends in antimicrobial resistance and serotypes of Streptococcus pneumoniae isolates in Asian countries: an Asian Network for Surveillance of Resistant Pathogens (ANSORP) study. Antimicrob. Agents Chemother. 56:1418-1426.
14. Liñares J, Ardanuy C, Pallares R, Fenoll A. 2010. Changes in antimicrobial resistance, serotypes and genotypes in Streptococcus pneumoniae over a 30-year period. Clin. Microbiol. Infect. 16:402-410.
15. Lynch JP III, Zhanel GG. 2009. Streptococcus pneumoniae: does antimicrobial resistance matter? Semin. Respir. Crit. Care. Med. 30:210-238.
16. Metlay JP, et al. 2000. Impact of penicillin susceptibility on medical outcomes for adult patients with bacteremic pneumococcal pneumonia. Clin. Infect. Dis. 30:520-528. (Pubitemid 30205299)
17. Moroney JF, et al. 2001. Clinical outcomes of bacteremic pneumococcal pneumonia in the era of antibiotic resistance. 2001. Clin. Infect. Dis. 33:797-805. (Pubitemid 32831836)
18. Mufson MA, Chan G, Stanek RJ. 2007. Penicillin resistance not a factor in outcome from invasive Streptococcus pneumoniae community-acquired pneumonia in adults when appropriate empiric therapy is started. Am. J. Med. Sci. 333:161-167. (Pubitemid 47181615)
19. Neuman MI, et al. 2007. Factors associated with antimicrobial resistance and mortality in pneumococcal bacteremia. J. Emerg. Med. 32:349-357. (Pubitemid 46710313)
20. Pallares R, et al. 1995. Resistance to penicillin and cephalosporin and mortality from severe pneumococcal pneumonia in Barcelona, Spain. N. Engl. J. Med. 333:474-480.
21. Pallares R, et al. 2002. The effect of cephalosporin resistance on mortality in adult patients with nonmeningeal systemic pneumococcal infections. Am. J. Med. 113:120-126. (Pubitemid 34804748)
22. Paterson DL, et al. 2004. International prospective study of Klebsiella pneumoniae bacteremia: implications of extended-spectrum betalactamase production in nosocomial infections. Ann. Intern. Med. 140:26-32. (Pubitemid 38055918)
23. Richter SS, et al. 2009. Changing epidemiology of antimicrobial-resistant Streptococcus pneumoniae in the United States, 2004-2005. Clin. Infect. Dis. 48:e23-e33. doi:10.1086/595857.
24. Schrag SJ, et al. 2004. Emergence of Streptococcus pneumoniae with very high-level resistance to penicillin. Antimicrob. Agents. Chemother. 48:3016-3023. (Pubitemid 38989169)
25. Silverstein M, Bachur R, Harper MB. 1999. Clinical implications of penicillin and ceftriaxone resistance among children with pneumococcal bacteremia. Pediatr. Infect. Dis. J. 18:35-41. (Pubitemid 29055267)
26. Song JH, et al. 2004. Clinical outcomes of pneumococcal pneumonia caused by antibiotic-resistant strains in Asian countries: a study by the Asian network for surveillance of resistant pathogens. Clin. Infect. Dis. 38:1570-1578.
27. Turett GS, Blum S, Fazal BA, Justman JE, Telzak EE. 1999. Penicillin resistance and other predictors of mortality in pneumococcal bacteremia in a population with high human immunodeficiency virus seroprevalence. Clin. Infect. Dis. 29:321-327. (Pubitemid 29380194)
28. Weinberger DM, et al. 2010. Association of serotype with risk of death due to pneumococcal pneumonia: a meta-analysis. Clin. Infect. Dis. 51:692-699.
29. Weinstein MP, Klugman KP, Jones RN. 2009. Rationale for revised penicillin susceptibility breakpoints versus Streptococcus pneumoniae: Coping with antimicrobial susceptibility in an era of resistance. Clin. Infect. Dis. 48:1596-1600.
30. Yu VL, et al. 2003. An international prospective study of pneumococcal bacteremia: correlation with in vitro resistance, antibiotics administered, and clinical outcome. Clin. Infect. Dis. 37:230-237. (Pubitemid 36930354)